Warning letter
Center for Fertility and Gynecology: warning letter of Oct 9, 2008
FDA warning letter 37626 · Los Angeles District Office
Key facts
| Reference number | 37626 |
|---|---|
| Company | Center for Fertility and Gynecology |
| Subject | Human Cells, Tissues & Cellular Products |
| Issue date | Oct 9, 2008 |
| Posted date | Oct 9, 2008 |
| Issuing office | Los Angeles District Office |
| Product type | Biologics |
| CFR sections cited | 1271.3(r), 1271.50(a), 1271.75(a), 1271.80(b), 1271.80(c), 1271.85(b), 1271.85(a), 1271.85(c), 1271.3(n), 1271.3(s), 1271.47(a), 1271.85(b)(2) |
| Inspection city | Tarzana |
| Inspection ZIP | 91356-2847 |
| Inspection start date | Jun 17, 2008 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: